F-18-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study

McKinley Eliot T.; Watchmaker Jennifer M.; Chakravarthy A. BapsiMeyerhardt Jeffrey A.Engelman Jeffrey A.Walker Ronald C.Washington M. KayCoffey Robert J.Manning H. Charles

首页> 外文期刊>Annals of nuclear medicine >F-18-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study

【24h】

F-18-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study

机译：F-18-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

This pilot study evaluated the utility of 3'-deoxy-3'18F-fluorothymidine (F-18-FLT) positron emission tomography (PET) to predict response to neoadjuvant therapy that included cetuximab in patients with wild-type KRAS rectal cancers.

著录项

来源
《Annals of nuclear medicine》 |2015年第6期|535-542|共8页
作者
McKinley Eliot T.; Watchmaker Jennifer M.; Chakravarthy A. BapsiMeyerhardt Jeffrey A.Engelman Jeffrey A.Walker Ronald C.Washington M. KayCoffey Robert J.Manning H. Charles;
展开▼
作者单位

Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Sch Med, Nashville, TN 37232 USA;

Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA;

Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USAVanderbilt Univ, Program Chem & Phys Biol, Nashville, TN 37232 USAVanderbilt Univ, Dept Radiat Oncol, Sch Med, Nashville, TN 37232 USADana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USATennessee Valley VA Healthcare Syst, Serv Radiol, Nashville, TN USAVanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类放射医学;
关键词
F-18-FLT; Rectal cancer; Cetuximab; EGFR; Treatment response;

F-18-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study

摘要

著录项

相关主题

期刊订阅